Microfluidics is an emerging and multidisciplinary field that is of great interest to manufacturers in medicine, biotechnology, and chemistry, as it provides unique tools for the development of point-of-care diagnostics,...
The
ongoing problem with the thrombogenicity and poor tissue integration
of synthetic vascular grafts demands the design of new surfaces that
simultaneously suppress thrombosis and promote endothelialization.
Lubricant-infused surfaces have shown outstanding results in preventing
clot formation; however, their innate ability to completely block
the surface, averts targeted binding of desired biomolecules. We report
a new class of expanded polytetrafluoroethylene (ePTFE) vascular grafts
that prevent blood coagulation and concurrently promote endothelial
cell adhesion. This is made possible by direct silanization of anti-CD34
antibody with the coupling agent and subsequent conjugation of the
silanized antibody to the ePTFE surface. In contrast to the conventional
methods, we eliminated the need to chemically modify the ePTFE substrate
for attaching the capturing ligand, and as a result preserved the
innate surface properties of the ePTFE substrate. This is crucial
for infiltrating the fluorine-based ePTFE substrate with a biocompatible
perfluorocarbon-based lubricant and ultimately creating a functional
and stable lubricant-infused layer. Compared to commercially available
ePTFE vascular grafts and the ones coated using conventional methods,
our developed ePTFE grafts significantly attenuate thrombin generation
and blood clot formation and specifically capture endothelial cells
from human whole blood while preventing nonspecific adhesion of undesirable
proteins and cells. The developed technology can be applied to other
biomarkers and biomaterials and can be tailored toward different biomedical
applications where biofunctionality and targeted binding are of importance.
Specific ranges of
dissolved oxygen (DO) concentrations must be
maintained in a waterbody for it to be hospitable for aquatic animals.
DO sensor designs can employ selectively permeable membranes to isolate
DO from untargeted compounds or organisms in waterbodies. Hence, the
DO concentration can be monitored and the health of the water can
be evaluated over time. However, the presence of bacteria in natural
waterbodies can lead to the formation of biofilms that can block pores
and prevent analyte from permeating the membrane, resulting in inaccurate
readings. In this work, we demonstrate the implementation of a fluorosilane-based
omniphobic lubricant-infused (OLI) coating on a selectively permeable
membrane and investigate the rate of biofilm formation for a commercially
available DO sensor. Coated and unmodified membranes were incubated
in an environment undergoing accelerated bacterial growth, and the
change in sensitivity was evaluated after 40, 100, 250, and 500 h.
Our findings show that the OLI membranes attenuate biofouling by 70%
and maintain sensitivity after 3 weeks of incubation, further demonstrating
that oxygen transfer through the OLI coating is achievable. Meanwhile,
unmodified membranes exhibit significant biofouling that results in
a 3.35 higher rate of decay in oxygen measurement sensitivity and
an over 70% decrease in static contact angle. These results show that
the OLI coating can be applied on commercially available membranes
to prevent biofouling. Therefore, OLI coatings are a suitable candidate
to suppress biofilm formation in the widespread use of selectively
permeable membranes for environmental, medical, and fluid separation
applications.
Micropatterned lubricant-infused biofunctional surfaces exhibit biofunctionality and omniphobicity simultaneously which leads to targeted cell attachment and alignment, both in surfaces and in microfluidic devices.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.